Omega-conotoxin peptides

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 1400, C07K 700, A61K 3800

Patent

active

055918212

ABSTRACT:
The present invention is directed to .omega.-conotoxin peptides having 24-30 amino acids, six cysteines which form disulfide bonds between the first and fourth, second and fifth, and third and sixth cysteines, respectively, and an internal sequence of Cys-Arg-Lys-Thr-Xaa.sub.1 -Tyr-Xaa.sub.2 -Cys-Cys-Ser-Gly-Ser-Cys (SEQ ID NO:1). The invention is further directed to .omega.-conotoxin peptides of the generic formula Cys-Xaa.sub.1 -Gly-Xaa.sub.2 -Gly-Ala-Xaa.sub.3 -Cys-Arg-Lys-Thr-Xaa.sub.4 -Tyr-Xaa.sub.5 -Cys-Cys-Ser-Gly-Ser-Cys-Xaa.sub.6 -Arg-Gly-Xaa.sub.7 -Cys (SEQ ID NO:2). Preferably, the C-terminus is amidated. These peptides also contain three disulfide bonds. Examples of .omega.-conotoxin peptides within the generic formula are MVIIC having the formula Cys-Cys-Gly-Lys-Gly-Ala-Xaa.sub.1 -Cys-Arg-Lys-Thr-Xaa.sub.2 -Tyr-Asp-Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Arg-Gly-Lys-Cys (SEQ ID NO:3), wherein Xaa is preferably Pro or Hyp (4-hydroxyproline) and Xaa.sub.2 is preferably Met or Nle (norleucine) and wherein preferably the C-terminus is amidated, and MVIID having the formula Cys-Gln-Gly-Arg-Gly-Ala-Ser-Cys-Arg-Lys-Thr-Xaa-Tyr-Asn-Cys-Cys-Ser-Gly-Se r-Cys-Asn-Arg-Gly-Arg-Cys (SEQ ID NO:4), wherein Xaa is preferably Met or Nle (norleucine), and wherein preferably the C-terminus is amidated. These peptides target the P-like subtypes of Ca.sup.2+ channels as well as the N-type Ca.sup.2+ channels.

REFERENCES:
patent: 4447356 (1984-05-01), Olivera et al.
patent: 4562175 (1985-12-01), Chang et al.
patent: 5051403 (1991-09-01), Miljanich et al.
Monje, et al, Neuropharmacology vol. 32, No. 11, pp. 1141-1149, 1993.
Olivera, et al, J. Biol. Chem., 266(33), 22067-71.
Olivera, et al, Biochemistry, 26, 2086-2090, 1987.
McIntosh, M. et al. (1982). Isolation and Structure of a Peptide Toxin from the Marine Snail Conus magus. Arch. Biochem. Biophys. 218: 329-334.
Olivera, B. M. et al. (1984). Purification and Sequence of a Presynaptic Peptide Toxin from Conus geographus Venom. Biochemistry 23:5087-5090.
Olivera, B. M. et al. (1985). Peptide Neurotoxins from Fish-Hunting Cone Snails. Science 230: 1338-1343.
Cruz, L. J. et al. (1986). Calcium Channel Antagonists. J. Biol. Chem. 261:6230-6233.
McCleskey, E. W. et al. (1987). w-Conotoxin: Direct and Persistent Blockade of Specific Types of Calcium Channels in Neurons But Not Muscle. Proc. Natl. Acad. Sci. USA 84:4327-4331.
Olivera, B. M. et al. (1987). Neuronal Calcium Channel Antagonists. Discrimination Between Calcium Channel Subtypes Using w-Conotoxin from Conus magus Venom. Biochemistry 26: 2086-2090.
Rivier, J. P. et al. (1987). Neuronal Calcium Channel Inhibitors. J. Biol. Chem. 262:1194-1198.
Yoshikami, D. et al. (1989). The Inhibitory Effects of Omega-Conotoxins on Ca Channels and Synapses. Ann. NY Acad. Sci. 560:230-248.
Olivera, B. M. et al. (1990). Diversity of Conus Neoropeptides. Science 249:257-263.
Olivera, B. M. et al. (1991). Conotoxins. J. Biol. Chem. 266:22067-22070.
Lundy, P. M. et al. (1991). Pharmacological evidence for an w-conotoxin, dihydropyridine-insensitive neuronal Ca.sup.2+ channel. Eur. J. Pharmacol. 206: 61-68.
Regan, L. J. et al. (1991). Ca.sup.2+ Channels in Rat Central and Peripheral Neurons: High-Threshold Current Resistant to Dihydropyridine Blockers and w-Conotoxin. Neuron 9:69-77.
Hillyard, D. R. et al. (1992). A New Conus Peptide Ligand for Mammalian Presynaptic Ca.sup.2+ Channels. Neuron 9:69-77.
Ramilo, C. A. et al. (1992). Novel a--and w-Conotoxins from Conus striatus Venom. Biochemistry 31:9919-9926.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Omega-conotoxin peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Omega-conotoxin peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega-conotoxin peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1765159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.